Characteristics | Value |
---|---|
No. of patients | 57 |
Age (years) | |
 Range | 38–75 |
 Mean ± SD | 57 ± 8 |
Histological type | |
 Endometrioid adenocarcinoma | 49 (86.0%) |
 Non-endometrioid adenocarcinoma | 8 (14.0%) |
Tumor grade | |
 G1 + G2 | 40 (70.2%) |
 G3 | 17 (29.8%) |
FIGO stage | |
 IA | 30 (52.6%) |
 IB | 7 (12.3%) |
 II | 9 (15.8%) |
 IIIA | 2 (3.5%) |
 IIIB | 1 (1.8%) |
 IIIC1 | 8 (14.0%) |
Myometrial invasion depth | |
 < 50% | 39 (68.4%) |
 ≥ 50% | 18 (31.6%) |
Cervical invasion | |
 Absent | 41 (71.9%) |
 Present | 16 (28.1%) |
Metastatic pelvic lymph node | |
 Negative | 49 (86.0%) |
 Positive | 8 (14.0%) |